Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1996-2-8
|
pubmed:abstractText |
Hirsutism is a common symptom of women affected by polycystic ovary syndrome (PCOS). The effectiveness of the antiandrogen flutamide alone was studied in 25 patients affected by PCOS with severe hirsutism for a period of 24 months. Seventeen of these patients had not been treated before and eight had had previous but unsatisfactory therapy. Nineteen patients showed a normal body weight (BMI < 25 kg/m2) whereas six were obese (BMI > 35 kg/m2). A chemical and endocrinological evaluation and an assessment of the degree of hirsutism, assigned by Ferriman-Gallwey score (mean 22 +/- 3.038), was performed under baseline conditions. Patients started treatment with flutamide (Eulexin, Schering-Plough, Kenilworth, USA) at the dose of 500 mg daily. A chronobiological assessment of gonadotropin episodic secretion and of gonadotropin response to GnRH challenge (10 micrograms in bolus) was done before and on day 7 of flutamide administration. During treatment, our patients showed a marked and significant reduction of hirsutism starting from a score of 6 and reaching the maximum (9.6 + 2.1) at 24 months of therapy. No relevant hormonal changes or side-effects were observed during therapy. Our data demonstrate that hirsutism in PCOS can rapidly and markedly respond to treatment with flutamide alone without important side-effects even if administered for a long period.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Androgen Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Dehydroepiandrosterone,
http://linkedlifedata.com/resource/pubmed/chemical/Dehydroepiandrosterone Sulfate,
http://linkedlifedata.com/resource/pubmed/chemical/Flutamide,
http://linkedlifedata.com/resource/pubmed/chemical/Follicle Stimulating Hormone,
http://linkedlifedata.com/resource/pubmed/chemical/Gonadotropin-Releasing Hormone,
http://linkedlifedata.com/resource/pubmed/chemical/Luteinizing Hormone
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0951-3590
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
221-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8540292-Adult,
pubmed-meshheading:8540292-Androgen Antagonists,
pubmed-meshheading:8540292-Dehydroepiandrosterone,
pubmed-meshheading:8540292-Dehydroepiandrosterone Sulfate,
pubmed-meshheading:8540292-Female,
pubmed-meshheading:8540292-Flutamide,
pubmed-meshheading:8540292-Follicle Stimulating Hormone,
pubmed-meshheading:8540292-Gonadotropin-Releasing Hormone,
pubmed-meshheading:8540292-Hirsutism,
pubmed-meshheading:8540292-Humans,
pubmed-meshheading:8540292-Luteinizing Hormone,
pubmed-meshheading:8540292-Polycystic Ovary Syndrome
|
pubmed:year |
1995
|
pubmed:articleTitle |
Prolonged treatment of hirsutism with flutamide alone in patients affected by polycystic ovary syndrome.
|
pubmed:affiliation |
Endocrinological Institute, University of Pisa, Italy.
|
pubmed:publicationType |
Journal Article
|